Syndrome of inappropriate antidiuresis and the current management of hyponatremia

Česká verzia

Authors: Ivica Lazúrová
Authors place of work: I. interná klinika LF UPJŠ a UNLP, Košice, Slovenská republika
Published in the journal: Vnitř Lék 2017; 63(9): 593-597
Category: Reviews

Summary

Hyponatremia defined as serum sodium lower than 135 mmol/L is the most common electrolyte abnormality in outpatients and also in hospitalized patients. It has been documented that hyponatremia is associated with significantly higher morbidity, mortality and longer hospitalization stay. Hyponatremia is manifested by variety of symptoms, from mild up to life threatening conditions. Syndrome of inappropriate antidiuresis (SIAD) is the most common type of hyponatremia. This article presents new aspects in the etiology, diagnosis, differential diagnosis ant treatment of the SIAD according to European guidelines.

Key words:
arginin-vasopressin-syndrome of inappropriate antidiuresis – diagnosis – hyponatremia – treatment

Zdroje

1. Spasovski G, Vanholder R, Allolio B et al. Clinical practice guidelines on diagnosis and treatment of hyponatremia. Eur J Endocrinol 2014; 170(3): G1-G47. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-13–1020>.

2. Sajadieh A, Binici Z, Mouridsen MR et al. Mild hyponatremia carriers a poor prognosis in community subjects. Am J Med 2009; 122(7): 679–686. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2008.11.033>.

3. Gill G, Huda B, Boyd A et al. Characteristics and mortality of severe hyponatremia – a hospital based study. Clin Endocrinol 2006; 65(2): 246–249.

4. Basu A, Ryder RE The syndrome of inappropriate antidiuresis is associated with excess long-term mortality: a retrospective cohort analyses. J Clin Pathol 2014; 67(9): 802–806.

5. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevelance, causes and consequences. Eur J Endocrinol 2010; 162(Suppl 1): S5-S12. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-09–1063>.

6. Shapiro DS, Sonnenblick M, Galperin I et al. Severe hyponatremia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J 2010; 40(8): 574–580. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1445–5994.2010.02217.x>.

7. Rudnay M, Lazúrová I. Prevalencia hyponatriémie u pacientov na internom oddelení. Vnitř Lék 2013; 59(10): 876–879.

8. Clayton JA, Le Jeune IR, Hall IP. Severe hyponatremia in medical in-patients: etiology, assessment and outcome. QJM 2006; 99(8): 505–511.

9. Tzoulis P, Carr H, Bagkeris E et al. Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input v.s. routine care. Endocrine 2017; 55(2): 539–546. Dostupné z DOI: <http://dx.doi.org/10.1007/s12020–016–1161–9>.

10. Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr 2015; 2: 146. Dostupné z DOI: <http://dx.doi.org/10.3389/fped.2014.00146>.

11. Nakajima H, Okada H, Hirose K et al. Cerebral salt-wasting syndrome and inappropriate antidiuretic hormone syndrome after subarachnoid hemorrhaging. Intern Med 2017; 56(6): 677–680. Dostupné z DOI: <http://dx.doi.org/10.2169/internalmedicine.56.6843>.

12. Gheorgiade M, Abraham WT, Albert NM et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007; 28(8): 980–988.

13. Faustini-Fustini M, Anagni M. Beyond semantics: defining hyponatremia in secondary adrenal insufficiency. J Endocrinol Invest 2006; 29(3): 267–269.

14. Inoue K, Nakayama T, Kamisawa A et al. Syndrome of inappropriate antidiuretic hormone accompanied by bilateral hypothalamic and anterior thalamic lesions with serum antiaquaporin 4 antibody. BMJ Case Rep 2017 Apr; 2017. pii: bcr-2017–219721. Dostupné z DOI: <http://dx.doi.org/10.1136/bcr-2017–219721>.

15. Fenske W, Stork S, Blechschmidt A et al. Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009; 94(1): 123–129. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2008–1426>.

16. Cohen DM, Ellison DH. Evaluating hyponatremia. JAMA 2015; 313(12): 1260–1261. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2014.13967>.

17. Lazúrová I. Syndróm neprimeranej sekrécie vazopresínu. Interná Med 2015; 15(7–8): 347–349.

18. Verbalis JG, Barsony J, Sugimura Y et al. Hyponatremia-induced osteoporosis. J Bone Miner Res 2010; 25(3): 554–563. Dostupné z DOI: <http://dx.doi.org/10.1359/jbmr.090827>.

19. Clayton JA, Rodgers S, Blakey J et al. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol 2006; 61(1): 87–95.

20. Liamis G, Filippatos TD, Elisaf MS. Thiazide-associated hyponatremia in the elderly: what the clinician need to know. J Geriatr Cardiol 2016; 13(2): 175–182. Dostupné z DOI: <http://dx.doi.org/10.11909/j.issn.1671–5411.2016.02.001>.

21. Burst V, Grundmann F, Kubacki T et al. Thiazide-associated hyponatremia, report of the hyponatremia registry: an observational multicenter international study. Am J Nephrol 2017; 45(5): 420–430. Dostupné z DOI: <http://dx.doi.org/10.1159/000471493>.

22. Katayama K, Tokuda Y. Mineralocorticoid responsive hyponatremia of the elderly: A systematic review. Medicine 2017; 96(27): e7154. Dostupné z DOI: <http://dx.doi.org/10.1097/MD.0000000000007154>.

23. Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol 2010; 162(Suppl 1): S13-S18. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-09–1057>.

24. Sterns RH, Capuccio JD, Silver SM et al. Neurologic sequalae after treatment of severe hyponatriemia: a multicenter perspective. J Am Soc Nephrol 1994; 4(8): 1522–1530.

25. De Sola-Morales O, Riera M. Urea for management of the syndrome of inappropriate secretion of ADH: a systematic review. Endocrinol Nutr 2014; 61(9): 486–492. Dostupné z DOI: <http://dx.doi.org/10.1016/j.endonu.2014.04.006>.

26. Schrier RW, Gross P, Gheorghiade M et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New Engl J Med 2006; 355(20): 2099–2112.

27. Rozen-Zvi B, Yahav D, Gheorghiade M et al. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am J Kidney Dis 2010; 56(2): 325–337. Dostupné z DOI: <http://dx.doi.org/10.1053/j.ajkd.2010.01.013>.